Kyntra Bio, Inc. (LON:0IL8)
London · Delayed Price · Currency is GBP · Price in USD 7.45
-0.20 (-2.61%)
At close: Feb 12, 2026
Kyntra Bio Employees
Kyntra Bio had 225 employees as of December 31, 2024. The number of employees decreased by 261 or -53.70% compared to the previous year.
Employees
225
Change (1Y)
-261
Growth (1Y)
-53.70%
Revenue / Employee
27.44K GBP
Profits / Employee
713.04K GBP
Market Cap
22.21M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2024 | 225 | -261 | -53.70% |
| Dec 31, 2023 | 486 | -106 | -17.91% |
| Dec 31, 2022 | 592 | 26 | 4.59% |
| Dec 31, 2021 | 566 | -33 | -5.51% |
| Dec 31, 2020 | 599 | 68 | 12.81% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| AstraZeneca | 94,300 |
| GSK plc | 68,629 |
| Haleon | 24,561 |
| Smith & Nephew | 17,000 |
| Abingdon Health | 124 |
| Renalytix | 46 |
| Arecor Therapeutics | 44 |
| Aptamer Group | 31 |
Kyntra Bio News
- 5 weeks ago - FibroGen (FGEN) Faces Option Delistings as of January 8th - GuruFocus
- 5 weeks ago - FibroGen (FGEN) Transforms into Kyntra Bio with a New Focus - GuruFocus
- 5 weeks ago - FibroGen Rebrands as Kyntra Bio to Reflect a New Era of Focus and Momentum - GlobeNewsWire
- 2 months ago - FibroGen (FGEN) Gains FDA Orphan Drug Status for Roxadustat - GuruFocus
- 2 months ago - FibroGen: FDA Grants Orphan Drug Designation To Roxadustat For MDS - Nasdaq
- 3 months ago - FibroGen, Inc. 2025 Q3 - Results - Earnings Call Presentation - Seeking Alpha
- 3 months ago - FibroGen Inc (FGEN) Q3 2025 Earnings Call Highlights: Strategic Moves Bolster Financial ... - GuruFocus
- 3 months ago - Q3 2025 FibroGen Inc Earnings Call Transcript - GuruFocus